Accordingly, treatment with a Dectin-1 antagonist improved insulin sensitivity in obese mice and reduced adipose tissue CD11c+ obesity-associated macrophages, while treatment with a Dectin-1 agonist did the opposite. This evidence concerns the gene ITGAX and Obesity.